Controversial FDA Regulator to Depart as Leadership Shakeup Continues
Vinay Prasad, a high-profile FDA official who oversaw vaccines, gene therapies, and rare-disease drug decisions, will leave the agency at the end of April amid ongoing leadership turnover and criticism over regulatory decisions and management style.